Yam plans protocol overhaul despite first successful V3 rebase

2020-09-23

  Yam, the decentralized finance (DeFi) sector’s original food-themed clone protocol, has successfully completed its first rebase since its V3 relaunch. Yam’s relaunch on September 18 followed the spectacular failure of Yam V2 last month — where a bug in the protocol’s unaudited code rendered governance impossible after only twoRead More →

EUR/USD meets another weekly close around 1.1850.

2020-09-18

  The euro opened at a daily high during the US session on Friday, but remained sideways. EUR/USD continued to fluctuate around 1.1850 and could not confirm the levels below 1.1800 or above 1.1900. EUR/USD is about to post small weekly gains hovering around 1.1850 at the end of Friday,Read More →

Cassava Technologies falls after record day, boost from analysts

2020-09-16

  Nasdaq:SAVA fell nearly 10% on Tuesday after rising nearly 90% earlier this week. Analysts raised their ratings after SAVA announced positive news about its Alzheimer’s clinical trial. NASDAQ:SAVA retreated Tuesday after nearly doubling in price on Monday, after Wall Street analysts were bullish on the biotech’s Phase 2B clinicalRead More →

NZD/USD shows signs of potential exhaustion

2020-09-09

  NZD/USD Analysis. Monetary policy conundrum adds uncertainty ahead of September RBNZ meeting. NZD/USD Rejected at the key weekly level around 0.6785. Signs of NZDUSD weakness. macd, RSI and bearish engulfment. IG client sentiment :Recent dovishness has invalidated the typical opposing sentiment view. NZD/USD faces resistance as RBNZ considers usingRead More →

AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.

2020-09-09

  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →